Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.

Finne, P; Auvinen, A; Koistinen, H; Zhang, W M; Määttänen, L; Rannikko, S; Tammela, T; Seppälä, M; Hakama, M; Stenman, U H

Finne, P; Auvinen, A; Koistinen, H; Zhang, W M; Määttänen, L; Rannikko, S; Tammela, T; Seppälä, M; Hakama, M; Stenman, U H.

Affiliation

Finne P; Department of Clinical Chemistry, Helsinki University Central Hospital, Finland. patrik.finne@hus.fi

J Clin Endocrinol Metab ; 85(8): 2744-7, 2000 Aug.

Article in En | MEDLINE | ID: mdl-10946875

Subject(s)

Biomarkers, Tumor/blood; Insulin-Like Growth Factor Binding Protein 3/blood; Insulin-Like Growth Factor I/analysis; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnosis; Aged; Confidence Intervals; False Positive Reactions; Humans; Insulin-Like Growth Factor I/metabolism; Male; Middle Aged; Odds Ratio; Prostate/anatomy & histology; Prostate/pathology; Prostatic Hyperplasia/blood; Prostatic Neoplasms/blood; Reproducibility of Results

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Insulin-Like Growth Factor I / Biomarkers, Tumor / Prostate-Specific Antigen / Insulin-Like Growth Factor Binding Protein 3 Type of study: Clinical_trials / Etiology_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 2000 Type: Article Affiliation country: Finland

Search on Google

XML

PubMed Links